| |
 |
|
Class Information
Number: 536/24.5
Name: Organic compounds -- part of the class 532-570 series > Organic compounds (class 532, subclass 1) > Carbohydrates or derivatives > Nitrogen containing > N-glycosides, polymers thereof, metal derivatives (e.g., nucleic acids, oligonucleotides, etc.) > Dna or rna fragments or modified forms thereof (e.g., genes, etc.) > Nucleic acid expression inhibitors
Description: Fragments of DNA or RNA which are effective inhibitors of transcription or translation.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6355790 |
Inhibition of HIV replication using a mutated transfer RNA primer |
Mar. 12, 2002 |
| 6352858 |
Antisense modulation of BTAK expression |
Mar. 5, 2002 |
| 6353055 |
Polynucleotide compositions |
Mar. 5, 2002 |
| 6350853 |
Conjugated peptide nucleic acids having enhanced cellular uptake |
Feb. 26, 2002 |
| 6350868 |
Antisense human fucosyltransferase sequences and methods of use thereof |
Feb. 26, 2002 |
| 6350935 |
Fruit-specific and ripening-regulation expansin gene to control fruit texture and softening |
Feb. 26, 2002 |
| 6348315 |
Polysome display in the absence of functional ssrA-RNA |
Feb. 19, 2002 |
| 6346380 |
Detection of variations in human H2 receptors |
Feb. 12, 2002 |
| 6346398 |
Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor |
Feb. 12, 2002 |
| 6346416 |
Antisense inhibition of HPK/GCK-like kinase expression |
Feb. 12, 2002 |
| 6346613 |
Composition and method for enhancing paracellular transport across cell layers |
Feb. 12, 2002 |
| 6346614 |
Hybrid oligonucleotide phosphorothioates |
Feb. 12, 2002 |
| 6344323 |
Compositions and methods for inhibiting cox-2 expression and treating cox-2 associated disorders by using cox-2 antisense oligonucleotides |
Feb. 5, 2002 |
| 6342356 |
Methods and regents for identifying synthetic genetic elements |
Jan. 29, 2002 |
| 6340674 |
Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides |
Jan. 22, 2002 |
| 6339066 |
Antisense oligonucleotides which have phosphorothioate linkages of high chiral purity and which modulate .beta.I, .beta.II, .gamma., .delta., .EPSILON., .zeta. and .eta. isoforms of human prot |
Jan. 15, 2002 |
| 6339071 |
Antisense oligonucleotide modulating cyclin E gene expression and therapeutic uses thereof |
Jan. 15, 2002 |
| 6335194 |
Antisense modulation of survivin expression |
Jan. 1, 2002 |
| 6335436 |
Oligonucleotides active against drug-resistant bacteria |
Jan. 1, 2002 |
| 6333314 |
Liposomes containing oligonucleotides |
Dec. 25, 2001 |
| 6333408 |
Oligonucleotides inhibitors of PAI-1 MRNA |
Dec. 25, 2001 |
| 6331399 |
Antisense inhibition of tert expression |
Dec. 18, 2001 |
| 6331526 |
Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides |
Dec. 18, 2001 |
| 6331617 |
Positively charged oligonucleotides as regulators of gene expression |
Dec. 18, 2001 |
| 6329141 |
Methods for transforming Phaffia strains, transformed Phaffia strains so obtained and recombinant DNA in said methods |
Dec. 11, 2001 |
| 6329203 |
Antisense modulation of glioma-associated oncogene-1 expression |
Dec. 11, 2001 |
| 6329346 |
Oligo-2'-deoxynucleotides and their use as pharmaceutical agents with antiviral activity |
Dec. 11, 2001 |
| 6329567 |
Methods for improving seeds |
Dec. 11, 2001 |
| 6326174 |
Enzymatic DNA molecules |
Dec. 4, 2001 |
| 6326193 |
Insect control agent |
Dec. 4, 2001 |
| 6326199 |
Gapped 2' modified oligonucleotides |
Dec. 4, 2001 |
| 6326358 |
Carbohydrate or 2'-modified oligonucleotides having alternating internucleoside linkages |
Dec. 4, 2001 |
| 6326478 |
Process for the synthesis of oligomeric compounds |
Dec. 4, 2001 |
| 6326487 |
3 modified oligonucleotide derivatives |
Dec. 4, 2001 |
| 6326488 |
Gene and genetic elements associated with sensitivity to chemotherapeutic drugs |
Dec. 4, 2001 |
| 6323003 |
Compositions and methods for activating genes of interest |
Nov. 27, 2001 |
| 6323029 |
Antisense modulation of glycogen synthase kinase 3 beta expression |
Nov. 27, 2001 |
| 6323184 |
Arteriovenous and venous graft treatments: methods and compositions |
Nov. 27, 2001 |
| 6323185 |
Anti-viral guanosine-rich oligonucleotides and method of treating HIV |
Nov. 27, 2001 |
| 6319711 |
Composition and method for inhibiting reverse transcript of a retrovirus |
Nov. 20, 2001 |
| 6319906 |
Oligonucleotide compositions and methods for the modulation of the expression of B7 protein |
Nov. 20, 2001 |
| 6320040 |
4-desmethyl nucleoside analogs and oligomers thereof |
Nov. 20, 2001 |
| 6316259 |
Antisense inhibition of glycogen synthase kinase 3 alpha expression |
Nov. 13, 2001 |
| 6316612 |
Xylofuranosly-containing nucleoside phosphoramidites and polynucleotides |
Nov. 13, 2001 |
| 6312900 |
Antisense oligonucleotide compositions and methods for the modulation of activating protein 1 |
Nov. 6, 2001 |
| 6312953 |
Bifunctional Crosslinking oligonucleotides adapted for linking to a target sequence of duplex DNA |
Nov. 6, 2001 |
| 6312956 |
Nuclear targeted peptide nucleic acid oligomer |
Nov. 6, 2001 |
| 6313375 |
Maize aquaporins and uses thereof |
Nov. 6, 2001 |
| 6313376 |
Maize aquaporins and uses thereof |
Nov. 6, 2001 |
| 6309882 |
Antisense inhibition of replication protein a p70 subunit |
Oct. 30, 2001 |
|
|
|
